共 36 条
- [21] Answer to the Letter to the Editor of K. Huang concerning "The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases" by van Tol FR, et al. [Eur Spine J (2020): DOI 10.1007/s00586-020-06599-x] [J]. EUROPEAN SPINE JOURNAL, 2021, 30 (06) : 1784 - 1785
- [22] Re S. S. !Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.: Cancer Res 2002;62:2708-14 -: Re K.!Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62:6015-20 -: Reply [J]. CANCER RESEARCH, 2004, 64 (08) : 2935 - 2936
- [27] Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel YC Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46 Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database Consortium [J]. EUROPEAN UROLOGY, 2019, 75 (02) : E34 - E35
- [28] Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.01.020 [J]. EUROPEAN UROLOGY, 2023, 84 (03) : E73 - E74
- [29] Re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol 2020;77:260-8 [J]. EUROPEAN UROLOGY, 2020, 77 (06) : E154 - E155
- [30] Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015; 67: 460-7 [J]. EUROPEAN UROLOGY, 2015, 68 (06) : E125 - E126